Mirada Medical is a leading international brand in medical imaging. We develop advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care.
Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere. We specialize in simplifying technically complex image quantification allowing clinicians to confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Our high value clinical software applications are used in prestigious cancer centers and hospitals worldwide.
Originally spun out of the University of Oxford, our team of dedicated engineers and world-renowned scientists is based in Oxford, England.
Mirada Medical Presents Multi-Center Studies Investigating Auto-contouring efficiency at U.S. Radiation Oncology meeting
Gaining greater workflow efficiency is an important requisite for treating more cancer patients with the most advanced radiotherapy methods.
Innovative UK Software Developer Presents Cost-Effective Alternative to Hybrid Pet/MRI Scanners at Royal College of Radiologist Meeting
The fusion of PET/CT and MRI scans to achieve the combined clinical benefits of PET/MRI “is now within reach of everyone,” according to Dr. Timor Kadir, Chief Science and Technology Officer of Mirada Medical.
Mirada Medical, a leading innovator in medical image analysis, announced they have formalized an agreement with General Electric Healthcare, Milwaukee, WI, whereby GE will license Mirada’s powerful automatic atlas-based contouring software for implementation on their AdvantageSim MD 9 virtual simulation software suite for advanced radiation therapy planning.
Mirada Medical Deformable Image Registration software is the highlight of multiple scientific studies being presented at the annual American Association of Physicists in Medicine (AAPM) meeting being held August 4-8 in Indianapolis, Indiana.